Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CYTK
HNGE
Add up to 3 more stocks
CYTK
Cytokinetics, Incorporated
-2.46%
$61.16-1.54Delayed quote: Oct 6, 2026, 10:25 AM EDT
Market Cap
$7.61B
52W Range
$54.30 - $88.31
HNGE
Hinge Health, Inc.
-1.69%
$96.69-1.66Delayed quote: Oct 6, 2026, 10:24 AM EDT
Market Cap
$7.48B
52W Range
$30.08 - $100.36
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 75.15 |
| Forward P/E | N/A | 41.70 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 21.73 |
| P/S Ratio | 107.25 | 10.39 |
| P/FCF Ratio | N/A | 26.04 |
| EV/EBITDA | N/A | 73.72 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 85.0% | 84.5% |
| Operating Margin | -695.4% | -92.9% |
| Net Margin | -1259.9% | 15.2% |
| ROE | N/A | 31.7% |
| ROA | -46.5% | 13.2% |
| ROIC | -39.8% | 26.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.66 | 1.34 |
| Quick Ratio | 6.66 | 1.30 |
| Debt/Equity | N/A | 0.02 |
| Interest Coverage | -5.89 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.